The retail superstore is adding a new feature to its Walmart+ plan — and customers will be happy.
President Biden Delivers The "Darkest, Most Un-American Speech Given By A President" Having successfully raged, ranted, lied, and yelled through...
The social categories that we belong to shape our understanding of the world in different ways.
A rising number of Americans say that immigration is the country’s biggest problem. Biden called for Congress to pass a bipartisan border and immigration...
A new UN report finds that the true global cost of producing food is $12.7 trillion more than consumers pay at the checkout counter. We pay...
An estimated 95% of US cities provide economic development tax incentives to woo corporate investors, taking billions away from schools.
Most Americans see China as the biggest threat to the US. But away from headline economic figures, China has a slew of challenges.
We wrote this four-part inflation series in response to the graph below, implying that prices are on the same inflation roller coaster ride as the 1970s....
The cost of housing remains a hot-button topic with both Millennials and Gen-Z. Plenty of articles and commentaries address the concern of supply and affordability,...
Last week, hundreds of NAIOP members from the U.S. and Canada attended NAIOP’s Chapter Leadership and Legislative Retreat (CL&LR) in Washington,...
The CADCHF currency pair represents the exchange rate between the Canadian Dollar and the Swiss Franc. It serves as a unique barometer... Read More... The...
The GBPINR (British Pound to Indian Rupee) exchange rate has seen notable fluctuations and trends in recent weeks. The context here is... Read More... The...
A commonly used measure of market liquidity is market depth, which refers to the quantity of securities market participants are willing to buy or sell...
- by New Deal democratLet’s take a look at two the big short leading and coincident indicators that were reported yesterday, respectively real retail...
Inflation around the world increased dramatically with the reopening of economies following COVID-19. After reaching a peak of 11 percent in the second...
Ramiro Ribeiro After six years as head of clinical development at Apellis Pharmaceuticals, Ramiro Ribeiro is joining EyePoint Pharmaceuticals as CMO. “The...
Until recently, China’s decelerating inflation was welcomed by the West, as it led to lower imported prices and helped reduce inflationary pressures....
The president will announce a series of housing proposals in his 2024 State of the Union address tonight.
Deterra Royalties (ASX:DRR) was established through a strategic demerger from Iluka Resources Ltd (ASX:ILU) in 2020. At the core of Deterra Royalties portfolio...
In the past 23 years, the U.S. has produced one budget surplus (fiscal 2001) and 22 budget deficits. The past four budget deficits, from fiscal 2020...
Damage repair, Claude Shannon, Elon Musk's pay, Intellectual obesity, Apple Vision Pro, Ignoring the market, Damodaran data updates, Apple packaging, Samsung,...
In the context of valuing companies, and sharing those valuations, I do get suggestions from readers on companies that I should value next. While...
Gather intel from executives behind six prospective mining stocks across six strategic commodities featured at PDAC 2024 in Toronto. The post Gather ’round...
Peter Coy used his column yesterday to beg President Biden not to use the term “greedflation” to explain the runup in inflation since the pandemic....
A new report from the National Academies of Science, Engineering, and Medicine (NASEM), An Updated Measure of Poverty: (Re)Drawing the Line, has hit...
Tech stocks are back in the driver's seat as markets look to another round of the Fed chairman's comments and a jobs report to extend recent...
You can blame failing demand and a bad partnership for the abrupt ending.
Here's what could happen next to Coca-Cola's shares.
Glimpse Of Sanity: Dartmouth Returns Standardized Testing For Admission After Failed Experiment In response to the virus pandemic and nationwide...
To build or to buy? That’s a classic question for pharma boardrooms, and Novo Nordisk is going with both. Beyond spending billions of dollars to expand...